title: In regards to Barkati et al. (Int J Radiat Oncol Biol Phys 2010;76:410-416).
authors.forename: Hans
authors.initials: H
authors.lastname: Christiansen
authors.forename: Ralph M W
authors.initials: RM
authors.lastname: Rödel
authors.forename: Christoph
authors.initials: C
authors.lastname: Matthias
authors.forename: Clemens F
authors.initials: CF
authors.lastname: Hess
authors.forename: Hendrik A
authors.initials: HA
authors.lastname: Wolff
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects / Q000379:methods; D018572:Disease-Free Survival; D005472:Fluorouracil / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D009959:Oropharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin; D005472:Fluorouracil